Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

CNS Pharmaceuticals

NASDAQ CNSP
$0.20 0.0084 4.29%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 11 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

1.22M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
967.66K
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
-
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
6.21M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-84.60 %

Upcoming events CNS Pharmaceuticals

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart CNS Pharmaceuticals

Stock analysis CNS Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.06 27.58
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
-0.27 3.97
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-0.05 10.54
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.0100 0.24
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
425.58 10.75

Price change CNS Pharmaceuticals per year

1.38$ 4.46$
Min Max

Summary analysis CNS Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure CNS Pharmaceuticals

Revenue and net income CNS Pharmaceuticals

All parameters

Stock news CNS Pharmaceuticals

All news
3 January 2023 в 20:15

CNS Pharmaceuticals Appoints Faith Charles as Chair of Board

3 January 2023 в 20:15

CNS Pharmaceuticals Appoints Faith Charles as Chair of Board

29 November 2022 в 01:05

CNS Pharmaceuticals Issues 1-for-30 Reverse Stock Split

29 November 2022 в 01:05

CNS Pharmaceuticals Issues 1-for-30 Reverse Stock Split

17 August 2022 в 14:23

CNS Pharmaceuticals downgraded to hold from buy at Maxim Group

About company CNS Pharmaceuticals

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center; and a development agreement with WPD Pharmaceuticals Inc. The company was founded in 2017 and is based in Houston, Texas.
Address:
2100 West Loop South, Houston, TX, United States, 77027
Company name: CNS Pharmaceuticals
Issuer ticker: CNSP
ISIN: US18978H1023
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2019-11-08
Sector: Healthcare
Industry: Biotechnology
Site: https://www.cnspharma.com

On which stock exchange are CNS Pharmaceuticals (CNSP) stocks traded?

CNS Pharmaceuticals (CNSP) stocks are traded on NASDAQ.

What is the ticker of CNS Pharmaceuticals stocks (CNSP)?

The stock ticker of CNS Pharmaceuticals’s stocks or in other words, the code is CNSP. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does CNS Pharmaceuticals (CNSP) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, CNS Pharmaceuticals (CNSP) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are CNS Pharmaceuticals (CNSP) stocks traded?

CNS Pharmaceuticals (CNSP) stocks are traded on the NASDAQ exchange in dollars.

What is the price of CNS Pharmaceuticals (CNSP) stocks today?

The current price of CNS Pharmaceuticals stocks on 14.05.2024 is 0.204 dollars. per share.

What is the dynamics of CNS Pharmaceuticals (CNSP) stocks from the beginning of the year?

CNS Pharmaceuticals (CNSP) quotes have increased by -82.86% from the beginning of the year up to 0.204 dollars. per 1 stocks.

How much did CNS Pharmaceuticals (CNSP) stocks increase in мае 2024?

This month CNS Pharmaceuticals (CNSP) quotes have increased by -6.42% to 0.204 dollars. per share.

How much are CNS Pharmaceuticals (CNSP) stocks worth?

Today, on October, 14.05.2024 CNS Pharmaceuticals’s (CNSP) stocks cost 0.204 dollars..

What is the market capitalization of CNS Pharmaceuticals (CNSP)?

Capitalization is the market value of CNS Pharmaceuticals (CNSP) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 14.05.2024, the market capitalization of CNS Pharmaceuticals (CNSP) is estimated at about 1215575 dollars.